The US Food and Drug Administration (FDA) has tagged Medtronic’s recall of certain Pipeline Vantage embolisation devices as ...
The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Medical device recalls are essential to patient safety, addressing critical issues in devices that may pose health risks. Here are some of the latest recalls reported to the FDA: ...
In a notice posted to the agency’s website, the FDA noted that on January 30, 2025, Medtronic (MDT) Neurovascular sent all affected customers an Urgent Medical Device Recall letter warning user ...
The FDA deemed a recall of some Medtronic Pipeline Vantage embolization devices serious after multiple deaths related to the ...
According to the FDA, the company has issued an urgent medical device recall, notifying all affected users of the recall on Jan. 30. The recall followed reports of the device's tube section ...
A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...
The FDA has labeled Smiths Medical's recall of ProPort Implantable Plastic Port as Class I, the most serious kind.
BD, Medtronic and Abbott were among the top 10 device companies with the highest number of late reports to the FDA, the study ...
The FDA recall affects more than 25,000 of the Fridley-run company’s devices and follows reports of 17 injuries.
Bengaluru: The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", following reports of the deaths of four patients.
The US Food and Drug Administration (FDA) has tagged the recall of software used ... by software failure modes while Smiths Medical issued a medical device correction for its software-affected ...